Does early initiation of Impella 2.5 prior to PCI improve survival and revascularization in patients with refractory cardiogenic shock complicating an acute myocardial infarction?
Early initiation of Impella 2.5 prior to PCI in patients with AMI and refractory cardiogenic shock is associated with improved survival and more complete revascularization.
The results of our study suggest that early initiation of hemodynamic support prior to PCI with Impella 2.5 is associated with more complete revascularization and improved survival in the setting of refractory CS complicating an AMI.
O’Neill et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: